Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menactra antibody response in children previously vaccinated with monovalent MenC
NCT00771849Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2003
- Primary completion
- Mar 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal A conjugate vaccine in meningococcal disease, sponsored by Sanofi. Started Aug 2003; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT00771849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771849.